EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404417/
https://www.ncbi.nlm.nih.gov/pubmed/37551312
http://dx.doi.org/10.2147/OTT.S433399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404417/
https://www.ncbi.nlm.nih.gov/pubmed/37551312
http://dx.doi.org/10.2147/OTT.S433399

Ejemplares similares